ArticleUrology case reports2025
Primary renal neuroendocrine tumor: A rare case and review of diagnostic and therapeutic challenges.
Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A case of renal primary neuroendocrine tumor (G3) in which 177Lu-PRRT was effective for disease control.Urology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary renal neuroendocrine tumors (NETs) are extremely rare and pose both diagnostic and therapeutic challenges due to their nonspecific presentation and overlap with more common renal masses. We report the case of a 49-year-old woman who presented with flank pain and was found to have a large well-differentiated Grade 2 renal NET. Histopathology revealed classic ribbon-like architecture with Ki-67 index of 3-7 %, and immunohistochemistry confirmed strong synaptophysin and CD56 positivity. Surgical resection via radical nephrectomy was curative. This case highlights the importance of histological evaluation and contributes to the limited literature review on renal NET diagnosis and management.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.